triple negative breast cancer; (ER-, PR-, HER2-)

From Aaushi
Jump to navigation Jump to search

Epidemiology

  • black women twice as likely as white women to be diagnosed with triple-negative breast cancer[3]
  • they are also more likely to die from the disease[3]

Pathology

Management

More general terms

References

  1. Jump up to: 1.0 1.1 1.2 1.3 Medical Knowledge Self Assessment Program (MKSAP) 17, 18. American College of Physicians, Philadelphia 2015, 18.
  2. Jump up to: 2.0 2.1 FDA Approval Notice. March 8, 2019 FDA approves atezolizumab for PD-L1 positive unresectable locally advanced or metastatic triple-negative breast cancer. https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm633065.htm
  3. Jump up to: 3.0 3.1 3.2 3.3 3.4 Winn S UC Davis researchers help decode the cause of aggressive breast cancer in women of color. Cancer Care. December 20, 2024 https://health.ucdavis.edu/news/headlines/uc-davis-researchers-help-decode-the-cause-of-aggressive-breast-cancer-in-women-of-color/2024/12